Used primarily as an intermediate in pharmaceutical synthesis, this compound plays a key role in the preparation of bioactive molecules through Suzuki-Miyaura cross-coupling reactions. The presence of the boronate ester group enables efficient carbon-carbon bond formation, allowing for the construction of complex aromatic frameworks found in drug candidates. Its piperazine moiety enhances solubility and influences pharmacokinetic properties, making it valuable in the development of central nervous system agents, kinase inhibitors, and receptor modulators. Commonly employed in medicinal chemistry research, it supports the rapid assembly of structurally diverse compounds for biological screening and lead optimization.